Pinnacle Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$13.6M |
| 2 |
Alaska Air
ALK
|
+$9.49M |
| 3 |
Delta Air Lines
DAL
|
+$7.84M |
| 4 |
Mueller Water Products
MWA
|
+$4.38M |
| 5 |
Bank of America
BAC
|
+$3.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LVLT
Level 3 Communications Inc
LVLT
|
+$45.4M |
| 2 |
KITE
Kite Pharma, Inc.
KITE
|
+$42.2M |
| 3 |
Lam Research
LRCX
|
+$19.8M |
| 4 |
Royal Caribbean
RCL
|
+$13.4M |
| 5 |
Qorvo
QRVO
|
+$11.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.94% |
| 2 | Communication Services | 14.2% |
| 3 | Healthcare | 13.83% |
| 4 | Industrials | 9.95% |
| 5 | Financials | 9.03% |
Similar funds
Pinnacle Associates's Q4 2017 Portfolio in Review
As of Q4 2017, Pinnacle Associates held 708 positions worth $5.2B, down 4% from $5.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Pinnacle Associates withdrew a net $370M in Q4 2017, closing 28 positions and reducing 401 holdings. Its most notable exit was Level 3 Communications Inc, an estimated $45.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Pinnacle Associates opened a new position in Intercept Pharmaceuticals, Inc. worth $12.6M.
- Pinnacle Associates's largest Q4 2017 buy was Intercept Pharmaceuticals, Inc.: 215,290 shares worth $12.6M.
- Pinnacle Associates added most to Delta Air Lines in Q4 2017, an estimated $7.84M increase.
- Pinnacle Associates's biggest Q4 2017 reduction was Lam Research, cutting an estimated $19.8M.
- Pinnacle Associates fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $45.4M.
- Pinnacle Associates's ten largest holdings make up 18% of its $5.2B portfolio in Q4 2017.
- Pinnacle Associates opened 42 new positions and closed 28 in Q4 2017.
- Pinnacle Associates's portfolio value fell 4% quarter-over-quarter to $5.2B.
Based on Pinnacle Associates's 13F filing for Q4 2017, filed 12 Feb 2018.